submit your CV directly:
Indianapolis Downtown, Inc.
Indy.gov
Hoosiers by Choice
Indy Hub - 5 Reasons to Move to Indianapolis
Livability Profile - Indianapolis
2023 Best School Districts in the Indianapolis Area
Indianapolis Cultural Districts
Your Guide to Indianapolis
Indy Airport - Named Best Airport for 12 Years
Niche Rankings - Marion County
Life in Indy
IU Health and the Indiana University School of Medicine are seeking an academically focused medical oncologist to join the GI Oncology Program in Indianapolis, Indiana. This position is designed for a candidate seeking to build a focused academic career in gastrointestinal oncology, with an emphasis on clinical trials, disease-site specialization, multidisciplinary care, education, and clinical/translational research.
The successful candidate will practice primarily within the IU Simon Comprehensive Cancer Center and/or affiliated IU Health oncology sites, with opportunities to focus on a defined area of GI oncology based on clinical and research interests. The position offers strong clinical trial infrastructure and the opportunity to participate in, develop, and lead investigator-initiated, cooperative group, and industry-sponsored clinical trials.
This is an academic opportunity for a motivated physician interested in becoming a clinical trialist and contributing to the growth of a high-impact GI oncology program.
Position Highlights
- Full-time academic employment opportunity focused on adult GI oncology patients
- Disease-site focused GI oncology practice with opportunity for further subspecialization
- Academic practice with emphasis on clinical care, clinical research, education, and multidisciplinary collaboration
- Opportunity to participate in and lead clinical trials, including investigator-initiated, cooperative group, and industry-sponsored studies
- Engagement with multidisciplinary tumor boards and disease-site teams
- Teaching and mentorship opportunities with fellows, residents, and medical students
- Practice open Monday–Friday
- Call: 4–6 weekends of call annually
Key Responsibilities
- Provide expert, disease-site focused care for patients with gastrointestinal malignancies and neuroendocrine tumors.
- Develop and maintain an academic clinical practice with emphasis on evidence-based care, clinical trials, and multidisciplinary treatment planning
- Participate in, develop, and lead clinical research studies in GI oncology, including therapeutic clinical trials
- Collaborate with surgery, radiation oncology, gastroenterology, radiology, pathology, precision genomics, research nursing, and clinical trial teams
- Support clinical trial accrual and contribute to the development of a robust GI oncology research portfolio
- Provide medical education and mentorship for fellows, residents, medical students, and other trainees
- Participate in multidisciplinary tumor boards, disease-site program development, and academic conferences
- Contribute to the academic mission of Indiana University School of Medicine through scholarship, education, and programmatic growth
Minimum Job Requirements
- MD or DO degree
- Ability to obtain Indiana medical license
- Demonstrated interest in GI oncology
- Strong interest in clinical trials and development of an academic career as a clinical investigator/clinical trialist
- Commitment to multidisciplinary care, education, and academic collaboration
Community Description
Indianapolis, Indiana, the 17th largest U.S. city, is a sophisticated city blending charm and culture with a wonderful balance of business and leisure. Residents of this dynamic city enjoy:
- Leading educational system and top-ranked universities, paired with a diverse population
- Vibrant downtown offering arts, theaters, world-class museums, zoo, concerts and memorials
- Named to U.S. News & World Report's 2023-2024 list of the best places to live in the United States
- Top ranked international airport: "Best Airport in North America" twelve consecutive years
- Ranked by Niche in 2023 as one of the most diverse counties in America, as well as one of the best cities to live in and buy a house in the country
- Historic neighborhoods with surrounding cultural districts and low cost of living
- Outdoor recreation includes golfing, boating and unique parks
- Home of the Colts (NFL), Fever (WNBA), Pacers (NBA), Indians (MiLB), Indianapolis 500 (IndyCar) and the nation's largest half marathon
- Close proximity to Chicago, St. Louis, Louisville, and Cincinnati
Healthcare System/Hospital Description
The Indiana University Melvin and Bren Simon Cancer Center is a patient care, research, and educational organization within the Indiana University School of Medicine, located on the school's main campus in Indianapolis.
Healthcare providers at IU Health Melvin and Bren Simon Cancer Center not only offer the highest level of patient care but many are engaged in research. As the only National Cancer Institute (NCI)-designated cancer center in the state of Indiana, IU Health Simon Cancer Center’s researchers are recognized for meeting rigorous criteria for world-class, state-of-the-art programs in multidisciplinary cancer research. NCI-designated cancer centers put significant resources into developing research programs, faculty and facilities that will lead to better approaches to prevention, diagnosis and treatment of cancer.
In 2022, the IU Health Melvin and Bren Simon Cancer Center was admitted as a member of the National Comprehensive Cancer Network, an alliance of 32 leading cancer centers devoted to patient care, research and education.
The mission is to advance the understanding, prevention and treatment of cancer throughout Indiana and the world with patient-centered care, acceleration of promising science and collaborative educational programs. Research is vigorous, innovative and devoted to taking improved cancer care into the future. In all, more than 200 physicians, nurses, social workers, techologists and researchers are working to develop cures for cancer.
That teamwork leads to clinical breakthroughs, such as turning the cure rate of testicular cancer from 10 percent to nearly 95 percent today, among many others. The benefits to patients are clear: a wide range of innovative treatment options, expert teams of diverse professionals focused on their specific cancer type, and attention to all cancer care needs in one setting.